TRUE-AHF Prognostic Classification (experimental prototype)
Patient variables
Enter the available measurements. Values are checked against broad plausibility limits.
About this prototype
TRUE-AHF (Trial of Ularitide Efficacy and Safety in Acute Heart Failure) was a randomized trial evaluating intravenous ularitide in patients with acute heart failure. The primary publication evaluated clinical outcomes, including cardiovascular mortality; it did not establish the exploratory weighted score implemented here as a validated bedside prognostic classification.
Interpretation and limitations
- The index is calculated using provisional, hand-assigned weights inherited from the supplied prototype.
- There is no established calibration, discrimination, external validation, or validated outcome horizon for this index.
- Input plausibility checks are not a substitute for clinical validation or data-quality review.
- For validated risk assessment, select a published tool whose population, endpoint, and setting match the clinical question, and consult its original derivation and validation evidence.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.